Clinical trial Recruiting at 2 sites Interventional Ages Any age to 17

Using alpha-defensin and synovial proteins to diagnose pediatric septic arthritis

Official title: Alpha-Defensin and Synovial Proteins to Improve Detection of Pediatric Septic Arthritis

Run by Hospital for Special Surgery, New York · NCT03704766 · Data updated 2026-11-12

This study is testing if certain proteins in joint fluid can help doctors better diagnose septic arthritis in children who might have joint infections.

Quick facts

Study typeInterventional
AgesAny age to 17 Years
SexAll
Enrollment442 (estimated)
SponsorHospital for Special Surgery, New York
Academic / other
Locations3 sites (Atlanta, Georgia and 2 other locations)
StatusRecruiting
StartedJune 28, 2016
Main results expectedNovember 2026
Study endsJanuary 2027
Registry record updatedJuly 29, 2026
Trial IDNCT03704766 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are pediatric patients under 18 years old who are undergoing joint aspiration due to suspected infection or inflammation.

Probably not a fit

Patients with major joint trauma within the past 8 weeks or those with a recent history of infection may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to improve the diagnosis of septic arthritis in children by evaluating the sensitivity and specificity of alpha-defensin and other synovial biomarkers in joint fluid samples. Pediatric patients under 18 years old, suspected of having joint infections, will undergo joint aspiration to collect synovial fluid for analysis. The study will compare samples from patients with suspected infections to those from normative controls undergoing unrelated procedures. Various assays will be performed on the collected fluid to identify potential biomarkers indicative of bacterial joint infections.

Why it matters

Potential benefit: If successful, this study could lead to faster and more accurate diagnoses of septic arthritis in children, potentially reducing the need for unnecessary surgical interventions.

How similar studies have gone: Previous studies have shown that the alpha-defensin assay has high sensitivity and specificity for diagnosing joint infections, indicating potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria- Septic Cases and Inflamed, Non-Septic Comparators:

* Synovial fluid is obtained to assess for infection or inflammatory/rheumatologic disease (all medium and large joints will be included: hip, knee, ankle, shoulder, subtalar, elbow, and wrist joints)
* Patients with recent antibiotic exposure are eligible to participate but will be analyzed separately

Inclusion Criteria- Normative Controls:

* Patients undergoing a procedure unrelated to infection (the procedure may be arthroscopy, or an open or percutaneous bony or soft tissue procedure)

Exclusion Criteria- All Participants:

* Family declines to participate/consent
* Patients with a major joint trauma (such as a documented ligament tear or fracture) within the past 8 weeks are not eligible to have that joint aspirated, but could have another joint aspirated

Exclusion Criteria- Normative Controls:

* A history of recent infection (within the past 3 months)
* Received antibiotics in the past 7 days

Where it's running

  • Children's Healthcare of Atlanta
    Atlanta, Georgia, United States
    Recruiting
  • Hospital for Special Surgery
    New York, New York, United States
    Recruiting
  • Campbell Clinic
    Collierville, Tennessee, United States
    Not yet recruiting

Study contacts

  • Principal investigator: Emily R Dodwell, MD, MPH — The Hospital for Special Surgery
  • Study coordinator: Grace Wang, BA
  • Email: wangg@hss.edu
  • Phone: 212-774-2121

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.